Millions of people with type 2 diabetes could receive better treatment thanks to a new, simple low-cost tool, according to groundbreaking research announced today at the Diabetes UK Professional ...

The experimental drug IC7Fc reduces artery-clogging fats and inflammation in mice, pointing to a potential new strategy for ...

Patients with a heart failure history and preserved ejection fraction appeared to benefit ...

Topline data were announced from a phase 3 trial evaluating CagriSema (cagrilintide/semaglutide) in patients with type 2 diabetes (T2D) inadequately ...

Natalie McCormick, PhD, of the Rheumatology and Allergy Clinical Epidemiology Research (RACER) Center within the Division of Rheumatology in the Mass General Brigham Department of Medicine, is the ...

CagriSema achieved superior weight loss of up to 14.2%, where up to 43% of the people achieved ≥15% weight loss and up to 24% ...

Preventing high blood glucose (pre-diabetes) from turning into type 2 diabetes with lifestyle changes could more than halve ...

Nearly 39 million American adults are currently living with diabetes, the latest data shows — and between 90% and 95% of those cases are type 2 diabetes. Type 1 diabetes, although it only makes up 5% ...

The unique type of diabetes is often misdiagnosed as type 2 diabetes at first ...

Diabetes affects every part of the body, causing symptoms like fatigue, weight gain, mood changes, and neuropathic pain, among others. These symptoms are not unique to diabetes: They are also common ...